FORTIS, NCT05126901: Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years |
|
|
| Recruiting | 3 | 98 | Europe, US | Ferric Maltol, Feraccru, Ferric Trimaltol, ST10, ST10-01, Ferrous sulfate | Shield Therapeutics | Anemia, Iron-deficiency | 04/24 | 07/24 | | |
